These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7896192

  • 21. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH, Leippe DM, Dunn LA, Liem A, Tindle RW, Fernando GJ, Phelps WC, Lambert PF.
    Cancer Res; 1995 Jun 15; 55(12):2635-9. PubMed ID: 7540107
    [Abstract] [Full Text] [Related]

  • 22. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, Ikeda Y, Kizaki M, Yoshinouchi M.
    Cancer Gene Ther; 2006 Mar 15; 13(3):234-41. PubMed ID: 16138119
    [Abstract] [Full Text] [Related]

  • 23. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.
    Fisher SG, Benitez-Bribiesca L, Nindl I, Stockfleth E, Muller M, Wolf H, Perez-Garcia F, Guzman-Gaona J, Gutierrez-Delgado F, Irvin W, Gissmann L.
    Gynecol Oncol; 1996 Apr 15; 61(1):73-8. PubMed ID: 8626121
    [Abstract] [Full Text] [Related]

  • 24. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T, Kraus I, Skomedal H, Nordstrøm T, Karlsen F.
    J Virol Methods; 2007 Jun 15; 142(1-2):204-12. PubMed ID: 17379322
    [Abstract] [Full Text] [Related]

  • 25. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK, Herman B.
    Cancer Epidemiol Biomarkers Prev; 1996 May 15; 5(5):329-35. PubMed ID: 9162297
    [Abstract] [Full Text] [Related]

  • 26. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS, Lee CJ, Um SJ, Park JS, Yang JM, Hwang ES.
    Gynecol Oncol; 2001 Feb 15; 80(2):168-75. PubMed ID: 11161855
    [Abstract] [Full Text] [Related]

  • 27. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N, Abraham P, Peedicayil A, Sridharan G, John S, Chandy G.
    Mol Diagn; 2004 Feb 15; 8(1):57-64. PubMed ID: 15230643
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y, Peng ZL, Lou JY, Wang H.
    Ai Zheng; 2006 Mar 15; 25(3):373-7. PubMed ID: 16536998
    [Abstract] [Full Text] [Related]

  • 30. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T, Saito M, Iwasaki E, Ochiya T, Takei Y, Hayashi S, Ono A, Hirao N, Nakamura M, Kubushiro K, Tsukazaki K, Aoki D.
    Int J Oncol; 2006 Sep 15; 29(3):541-8. PubMed ID: 16865269
    [Abstract] [Full Text] [Related]

  • 31. [Experimental studies of using real-time fluorescence quantitative PCR and RT-PCR to detect E6 and E7 genes of human papillomavirus type 16 in cervical carcinoma cell lines].
    Chen YY, Peng ZL, Liu SL, He B, Hu M.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 15; 38(3):443-6. PubMed ID: 17593827
    [Abstract] [Full Text] [Related]

  • 32. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
    Tan TM, Ting RC.
    Cancer Res; 1995 Oct 15; 55(20):4599-605. PubMed ID: 7553636
    [Abstract] [Full Text] [Related]

  • 33. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
    Song SH, Lee JK, Seok OS, Saw HS.
    Gynecol Oncol; 2007 Mar 15; 104(3):732-8. PubMed ID: 17188341
    [Abstract] [Full Text] [Related]

  • 34. HPV-16 E6-E7 differential transcription induced in Siha cervical cancer cell line by interferons.
    De Marco F, Marcante ML.
    J Biol Regul Homeost Agents; 1993 Mar 15; 7(1):15-21. PubMed ID: 7688490
    [Abstract] [Full Text] [Related]

  • 35. Genomic aberrations of human papillomavirus recovered from cervical cancers.
    Pao CC, Yao DS, Lin CY, Lee SC, Su HT, Lin SC.
    Biochem Biophys Res Commun; 1996 May 06; 222(1):116-20. PubMed ID: 8630054
    [Abstract] [Full Text] [Related]

  • 36. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Jonson AL, Rogers LM, Ramakrishnan S, Downs LS.
    Gynecol Oncol; 2008 Nov 06; 111(2):356-64. PubMed ID: 18755502
    [Abstract] [Full Text] [Related]

  • 37. The pro-angiogenic factors stimulated by human papillomavirus type 16 E6 and E7 protein in C33A and human fibroblasts.
    Xi L, Wang S, Wang C, Xu Q, Li P, Tian X, Wu P, Wang W, Deng D, Zhou J, Ma D.
    Oncol Rep; 2009 Jan 06; 21(1):25-31. PubMed ID: 19082439
    [Abstract] [Full Text] [Related]

  • 38. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells.
    Luczak MW, Jagodzinski PP.
    Cancer Lett; 2008 Dec 08; 272(1):53-60. PubMed ID: 18687520
    [Abstract] [Full Text] [Related]

  • 39. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
    Chang CH, Chen TH, Hsu RC, Chou PH, Yang JJ, Hwang GY.
    J Clin Virol; 2005 Jan 08; 32(1):33-7. PubMed ID: 15572004
    [Abstract] [Full Text] [Related]

  • 40. [The biological activities of the human papillomavirus type 16 E6/E7 cDNAs cloned from the SiHa cervical carcinoma cell line].
    Tamada Y.
    Hokkaido Igaku Zasshi; 1993 Nov 08; 68(6):849-61. PubMed ID: 8112710
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.